Original language | English |
---|---|
Pages (from-to) | 3001 |
Number of pages | 1 |
Journal | Journal of Clinical Oncology |
Volume | 33 |
Issue number | 15 supplement |
DOIs | |
Publication status | Published - 20 May 2015 |
Event | Annual Meeting of the American Society of Clinical Oncology (ASCO) - Chicago, United States Duration: 31 May 2013 → 4 Jun 2013 |
Association of response to programmed death receptor 1 (PD-1) blockade with pembrolizumab (MK-3475) with an interferon-inflammatory immune gene signature
Antoni Ribas, Caroline Robert, F. Stephen Hodi, Jedd D. Wolchok, Anthony M. Joshua, Wen-Jen Hwu, Jeffrey S. Weber, Hassane M. Zarour, Richard Kefford, Andrey Loboda, Andrew Albright, Soonmo Peter Kang, Scot Ebbinghaus, Jennifer Yearley, Erin Murphy, Michael Nebozhyn, Jared K. Lunceford, Terri McClanahan, Mark Ayers, Adil Daud
Research output: Contribution to journal › Meeting abstract